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Abstract: The electrochemical behavior of citalopram was studied by square-wave and 
square-wave adsorptive-stripping voltammetry (SWAdSV). Citalopram can be reduced 
and accumulated at a mercury drop electrode, with a maximum peak current intensity 
being obtained at a potential of approximately 21.25 V vs. AgCl/Ag, in an aqueous 
electrolyte solution of pH 12. A SWAdSV method has been developed for the 
determination of citalopram in pharmaceutical preparations. The method shows a 
linear range between 1.0  1027 and 2.0  1026 mol L21 with a limit of detection of 5 
 1028 mol L21 for an accumulation time of 30 s. The precision of the method was 
evaluated by assessing the repeatability and intermediate precision, achieving good 
relative standard deviations in all cases (2.3%). The proposed method was applied to 
the determination of citalopram in five pharmaceutical products and the results 
obtained are in good agreement with the labeled values.
Keywords: Citalopram, SSRI, hanging mercury drop electrode, adsorptive-stripping 
voltammetry, pharmaceutical analysis
INTRODUCTION
Citalopram (CTL) (Figure 1), a selective serotonin re-uptake inhibitor (SSRI)
developed by H. Lundbeck A/S (Denmark), is indicated for the symptomatic
relief of depressive illness.
For drug development and for treatment purposes it is very important to
be able to quantify the drug and its metabolites in a wide variety of samples
(serum, plasma, urine, and pharmaceutical products) to establish its
pharmacokinetics, metabolic pathway, dosage, etc. This implies the need for
analytical methods with high sample-throughput, low limits of detection,
and low maintenance costs.
Usually CTL and its metabolites are analyzed using high performance
liquid chromatography (HPLC) coupled with spectrometric detectors,
ultraviolet/diode array (Skibinski and Misztal 2005; Frahnert et al. 2003;
Duverneuil et al. 2003; Berzas et al. 2002; Tournel et al. 2001), mass spectro-
metric (Pistos et al. 2004; Gutteck and Rentsch 2003; Kollroser and Schober
2003), and fluorimetric (Meng and Gauthier 2005; Raggi et al. 2003;
Waschgler et al. 2002; Macek et al. 2001; Lacassie et al. 2000). This wide-
spread usage of HPLC methods is justified by the high sensitivity and the
low limit of detection usually obtained and the possibility of simultaneous
analysis of the drug and its metabolites increases its use even further. The
main disadvantages of HPLC are the relatively long analysis times and high
acquisition and maintenance costs. Several other methods, based on electro-
phoresis (Flores et al. 2004; Andersen et al. 2003; Mandrioli et al. 2003),
micellar electrokinetic capillary chromatography (Labat et al. 2002;
Pedersen-Bjergaard and Halvorsen 2000), isotachophoresis (Buzinkaiova
and Polonsky 2000), gas chromatography (Berzas et al. 2004; Martinez
et al. 2004; Lacassie et al. 2000; Eap et al. 1998), thin layer chromatography
(Misztal and Skibinski 2001), and UV spectrophotometry (Sagar 2004), have
also been described. No official quantification methods are reported in the
Figure 1. Chemical structure of citalopram.
various available pharmacopoeias. Until now no electrochemical studies on
the determination of CTL have been reported.
Adsorptive-stripping voltammetry (AdSV) is a technique mainly used for
the analysis of organic compounds, which can be accumulated at, for example,
the hanging mercury drop electrode (HMDE) surface and afterwards stripped
off by applying a potential scan (Wang 1985). The introduction of high-
scan-rate voltammetric techniques, for example square-wave voltammetry
(SWV), increases the sensitivity of AdSV even further (Barros et al. 1999).
The present paper shows that CTL exhibits adsorption onto the mercury
electrode surface. By using this phenomenon and by accumulation of the
compound at the HMDE prior to a square-wave voltammetric scan, a high
sensitivity can be achieved in its determination. The effect of several exper-
imental parameters on the analytical signal of CTL was evaluated in order
to develop a square-wave adsorptive-stripping voltammetric (SWAdSV)
method for its determination in pharmaceutical products. The proposed
method was successfully applied to the quantification of CTL, in the
presence of excipients, in five commercial pharmaceutical products.
EXPERIMENTAL
Apparatus
Voltammetric measurements, using SWV and SWAdSV, were performed
using an Autolab PGSTAT12 (Metrohm-EcoChemie) potentiostat, controlled
by a PC by use of GPES 4.9 software from Metrohm-EcoChemie, and a
Metrohm 663 VA stand containing a three-electrode cell (all Metrohm).
This voltammetric cell consisted of a multimode mercury working
electrode, used in the static mercury-drop position (SMDE), an Ag/AgCl/
KCl 3mol L21 reference electrode, and a glassy carbon auxiliary electrode.
Reagents and Solutions
A CTL hydrobromide standard was kindly provided by H. Lundbeck A/S
(Denmark) and used without further purification. Stock solutions of CTL
were prepared by dissolution of precisely weighed amounts of the standard
in deionized water. These stock solutions were diluted with deionized water
and electrolyte solution to furnish the desired concentration. All other
reagents, of p.a. quality, were purchased from Merck and Sigma–Aldrich.
All solutions were prepared in deionized water (conductivity ,0.1mS cm21).
For the optimization of electrolyte pH several universal buffers
(I ¼ 0.3mol L21) (Ferna´ndez and Martin 1977) between pH 1.9 and 11.6
were used. After optimization, a pH 12.0 NaOH-KCl electrolyte solution
(I ¼ 0.1mol L21) was used.
Procedures
General Procedure
To obtain the background voltammogram, a 10.00 or 15.00mL volume of the
supporting electrolyte was introduced in a voltammetric cell and purged with
oxygen-free nitrogen for 10min. The required accumulation potential (Eacc)
was then applied to the electrode for a selected accumulation time (tacc) while
the solution was stirred. Finally, stirring was stopped and a square-wave voltam-
mogram was recorded by applying a scan in the negative direction. After
recording the background voltammogram, an aliquot of the analyte (standard
or sample) solution was added and the procedure was repeated.
Validation Procedure
When the optimum experimental conditions had been found, validation of the
method was performed. For this purpose, the linear range, limit of detection
(LOD), limit of quantification (LOQ), repeatability, and intermediate
precision were evaluated (The United States Pharmacopoeia 2000).
The linear range was determined by analyzing CTL solutions in the range
1.0  1027 to 6.0  1026mol L21 for tacc values of 10 and 30 s. The LOD and
LOQ were calculated from the linear calibration plot (Miller and Miller 2000).
Repeatability and intermediate precision were assessed at three concen-
trations. CTL solutions of 6.0  1027, 1.4  1026, and 2.2  1026mol L21
were used for tacc 10 s and 6.0  1027, 1.1  1026, and 1.6  1026mol L21
solutions were evaluated for tacc 30 s. To assess the repeatability, five
replicate measurements of each solution were made in a short period of
time. To determine intermediate precision, the solutions were each analyzed
five times per day for three consecutive days.
Pharmaceutical Analysis
The pharmaceutical products used for evaluation of the adequacy of the
developed method were purchased in Belgium and Spain, because CTL-
containing pharmaceuticals are not commercialized in Portugal. All these
products have a labeled CTL-value of 20mg per tablet. For analysis, 10
tablets of each product were weighed, finely powdered, and a mass equival-
ent to about 10.4mg of CTL was dissolved in 100.0mL of deionized water
by sonication for 15min. This solution was then diluted 100-fold with
electrolyte and an adequate volume of the resulting solution was added to
15.00mL of electrolyte contained in the voltammetric cell. Quantification
was carried out using the standard addition method by adding increasing
quantities of a CTL standard directly to the sample solution contained in
the voltammetric cell. This procedure was repeated in triplicate for each
pharmaceutical. There was no need for prior filtration of the sample because
a large dilution was made and the standard addition method was used.
RESULTS AND DISCUSSION
Method Development
The electrochemical behavior of CTL was studied by SWV and SWAdSV
and an analytical signal was only obtained at high pH values (between 10
and 12), which increased with increasing electrolyte pH. A maximum peak
current intensity (ip), with a good repeatability, was obtained at pH 12. At
this pH, CTL presented a reduction peak at approximately 21.25V, which
increased with increasing tacc (Figure 2a). For a 5.0  1027mol L21 CTL
Figure 2. Square-wave adsorptive-stripping voltammetry of a 5.0  1027mol L21
CTL solution in an electrolyte of pH 12. Eacc ¼ 20.8V; f ¼ 120Hz; DEs ¼ 4mV;
DEp ¼ 30mV. (a) Voltammograms for tacc ¼ 0; 5; 10; 30; 60; and 120 s. (b) Effect
of tacc on ip.
Table 1. Characteristics of the calibration plots of CTL obtained with the proposed
method
tacc (s) 10 30
Regression equation
(2 ip (A); CCTL
(mol L21))
2ip ¼ (0.246+ 0.004)CCTL
2 (3.57+ 0.50)  1028
2ip ¼ (0.419+ 0.004)CCTL
þ (2.90+ 3.50)  1029
n 9 7
Linear range
(mol L21)
3.00  10272 3.00  1026 1.00  10272 2.00  1026
Correlation
coefficient
0.9990 0.9998
LOD (mol L21) 1.2  1027 4.7  1028
LOQ (mol L21) 4.0  1027 1.6  1027
solution this increase is significant for up to approximately 150 s (Figure 2b)
at an optimized Eacc of 20.8V, after which the increase of ip levels off,
possibly because of saturation coverage of the drop and/or competitive
adsorption.
Several experimental parameters related to the square-wave potential
scan, for example frequency ( f ), pulse step (DEs), and pulse amplitude
(DEp), were studied and optimized to obtain maximum ip and repeatability.
These parameters are interrelated and have a combined effect on the analytical
signal. Different values for f (102 2000Hz), DEs(12 15mV), and DEp
(5–100mV) were used, and led to the optimum conditions: f ¼ 300Hz,
DEs ¼ 3mV, and DEp ¼ 50mV.
Table 2. Results from evaluation of the precision
Parameter tacc 10 s tacc 30 s
Repeatability (RSD %) 1.7 (0.60) 0.9 (0.60)
1.2 (1.4) 1.0 (1.1)
0.6 (2.2) 0.4 (1.6)
Intermediate precision (RSD %) 2.3 (0.60) 1.4 (0.60)
1.7 (1.4) 1.1 (1.1)
1.1 (2.2) 0.6 (1.6)
Concentrations, in mmol L21, are given in parentheses.
Figure 3. Typical SWAdSV analysis of CTL in a pharmaceutical using the standard
addition method. Standard additions of CTL (1027mol L21): 0 to 6.00 (increments of
1.00). Eacc ¼ 20.8V; tacc ¼ 30 s; f ¼ 300Hz; DEs ¼ 3mV; and DEp ¼ 50mV.
Method Validation
Table 1 lists the achieved linear range, and theLODandLOQvalues obtained in
the voltammetric determination of CTL for accumulation times of 10 s and 30 s.
The results from assessment of the precision, expressed as the relative
standard deviation (RSD), are listed in Table 2. These results imply the
method is precise and also confirm the stability of the drug solutions.
Application
In the application of the SWAdSV method to the quantification of CTL in
pharmaceuticals, analyses were performed using the optimized conditions,
tacc of 30 s, and seven standard additions between 0 and 6.00  1027mol L21
(Figure 3). In Table 3 the results obtained are shown and it can be
concluded, when compared to the labeled values (20mg per tablet), that
they are accurate.
CONCLUSION
Based on the electrochemical behavior of CTL, a SWAdSV analytical meth-
odology for its quantification in pharmaceuticals was developed. The method
Pharmaceutical CCTL (10
27mol L21)a CCTL (mg/tablet) CCTL (mg/tablet)
b
Citalopram ratiopharm 2.06 20.5 20.2+ 0.4
1.98 19.7
2.05 20.4
Cipramil (Lundbeck) 4.47 17.9 18.8+ 1.8
5.24 20.9
4.40 17.6
Citalopram Sandoz 4.65 18.4 19.7+ 1.1
5.16 20.5
5.04 20.1
Merck Citalopram 5.29 21.0 19.7+ 1.5
4.54 18.0
5.03 20.0
Citalopram EG 5.03 19.9 19.7+ 0.2
4.96 19.8
4.88 19.5
aObtained in the voltammetric cell.
bMean+ standard deviation.
Table 3. Results of the quantification of CTL in several pharmaceuticals
was successfully applied as a good alternative to chromatographic methods
for the determination of CTL in several pharmaceuticals. The developed
SWAdSV method has the advantages of significantly reducing the analysis
time and costs and obtaining a high sample rate.
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